Lincocin (Lincomycin)

Lincocin is a lincosamide antibiotic used to manage infections caused by susceptible bacteria. It is employed in several clinical settings where gram‑positive or anaerobic pathogens are implicated.

• Skin and soft‑tissue infections: reduces bacterial load and promotes healing.
• Bone and joint infections: eradicates pathogens in osteomyelitis and septic arthritis.
• Intra‑abdominal infections: treats mixed aerobic‑anaerobic infections following surgery or perforation.
• Respiratory tract infections: effective against certain community‑acquired pneumonia caused by susceptible strains.
• Septicemia: used when bloodstream infection is caused by lincomycin‑sensitive organisms.

• Lincomycin inhibits bacterial protein synthesis by binding to the 50S subunit of the ribosome, preventing peptide chain elongation. This action blocks the translocation step of translation, leading to a bacteriostatic effect against susceptible gram‑positive and anaerobic organisms.

Adverse reactions may occur with lincomycin therapy and are categorized by frequency and severity.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: may be watery and self‑limiting.
• Vomiting: occasional episodes after dosing.
• Abdominal pain: cramp‑like discomfort.
• Rash: transient skin erythema.
• Eosinophilia: mild increase in eosinophil count.

Serious or Rare Side Effects

• Pseudomembranous colitis: severe colonic inflammation.
• Anaphylaxis: acute, potentially life‑threatening allergic reaction.
• Hepatic dysfunction: elevated liver enzymes or jaundice.
• Neutropenia: significant reduction in neutrophil count.
• Stevens‑Johnson syndrome: severe mucocutaneous reaction.
• Renal impairment: acute kidney injury in susceptible patients.

Lincomycin should be used with careful clinical assessment and monitoring.

• Assess renal function: adjust therapy in patients with renal insufficiency.
• Monitor liver enzymes: watch for hepatic toxicity during prolonged use.
• History of colitis: avoid or use with caution in patients with prior Clostridioides difficile infection.
• Known hypersensitivity: discontinue if allergic reactions develop.
• Use in pregnancy: evaluate risk‑benefit ratio as safety data are limited.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lincomycin may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Neuromuscular blocking agents: may potentiate muscle weakness.
• Methotrexate: increased risk of hematologic and hepatic toxicity.

Moderate Interactions (Monitor Closely)

• Oral contraceptives: possible reduction in contraceptive effectiveness.
• Warfarin: may enhance anticoagulant effect, requiring INR monitoring.
• Probenecid: may decrease renal clearance of lincomycin.
• Erythromycin: competitive inhibition at the bacterial ribosome, potentially altering activity.